These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 21993183)
21. Extracorporeal management of valproic acid toxicity: a case report and review of the literature. Al Aly Z; Yalamanchili P; Gonzalez E Semin Dial; 2005; 18(1):62-6. PubMed ID: 15663767 [TBL] [Abstract][Full Text] [Related]
22. [Reversible parkinsonism induced by prolonged treatment with valproate]. Barroso B Therapie; 2002; 57(4):410-1. PubMed ID: 12422564 [No Abstract] [Full Text] [Related]
23. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug. Hauben M; Reich L Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014 [No Abstract] [Full Text] [Related]
24. Parkinsonism in a nursing home: underrecognition. Friedman JH; Fernandez HH; Trieschmann MM J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697 [TBL] [Abstract][Full Text] [Related]
25. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication]. Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788 [No Abstract] [Full Text] [Related]
26. Successful reintroduction of valproic acid after the occurrence of pancytopenia. Stewart JT Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938 [TBL] [Abstract][Full Text] [Related]
28. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Silver M; Factor SA Parkinsonism Relat Disord; 2013 Aug; 19(8):758-60. PubMed ID: 23632325 [TBL] [Abstract][Full Text] [Related]
29. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance. Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180 [TBL] [Abstract][Full Text] [Related]
31. Valproate-induced Parkinsonism in epilepsy patients. Jamora D; Lim SH; Pan A; Tan L; Tan EK Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396 [TBL] [Abstract][Full Text] [Related]
32. Stuttering as a side-effect of divalproex sodium. Aukst-Margetić B; Margetić B Psychiatry Clin Neurosci; 2008 Dec; 62(6):748. PubMed ID: 19068016 [No Abstract] [Full Text] [Related]
33. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician. Dutta S; Reed RC J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100 [TBL] [Abstract][Full Text] [Related]
34. Septo-optic dysplasia as a manifestation of valproic acid embryopathy. McMahon CL; Braddock SR Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259 [TBL] [Abstract][Full Text] [Related]
35. [Parkinsonism due to the medication]. Louter M; Tromp SC Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308 [TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome in women using valproate: a review. Bilo L; Meo R Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099 [TBL] [Abstract][Full Text] [Related]
37. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit. Boggs JG; Preis K Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337 [TBL] [Abstract][Full Text] [Related]
38. A case of severe parkinsonism in an elderly person induced by valproic acid. Tada H; Ogihara T; Nakamura T; Sasayama D; Sugiyama N; Takahashi Y; Washizuka S; Amano N Psychogeriatrics; 2017 Jan; 17(1):76-77. PubMed ID: 26757408 [No Abstract] [Full Text] [Related]